TP53 and acute myeloid leukemia: In multivariate analysis, TP53 mutations were the only factor significantly associated with the overall survival of AML (hazard ratio 9.372, p = 0.007) when age, WBC count, and the presence of complex karyotypes and MR genes were adjusted (Supplementary Table S2).